In addition, ELISPOT assays using cells from individuals with psoriasis showed that IL-9 had no ex vivo effects on numbers of IFN- γ secreting CD4+ T cells, suggesting that IL-9 makes no contribution on the Th1 component of the disease (Figure 6E). Here, IL9 is linked to psoriasis.